無料プレビュー

Smith & Nephew plc (SNN) · New York Stock Exchange

プロフィール

SMITH & NEPHEW PLC develops and commercializes medical technology and devices focused on surgical and wound care. The company offers orthopaedic implants and instruments, sports medicine and ENT products, and advanced wound management therapies and related medical devices. Its operations are organized into three global business units: Orthopaedics, Sports Medicine & ENT, and Advanced Wound Management. The company sells its products and services worldwide through healthcare channels, including hospitals, clinics and other medical providers.

主要指標

株価: $26.96 (+0.26%)
時価総額: 113億ドル
PER（今期予想）: 12.3
PBR: 2.2
配当利回り: 2.95%
52週レンジ: $26.12 – $37.51
業種: Healthcare / Medical - Devices
上場: New York Stock Exchange
構成銘柄: —

比較会社: ABT Abbott Laboratories、MDT Medtronic Plc、SYK Stryker Corporation、BSX Boston Scientific Corporation、EW Edwards Lifesciences Corporation、DXCM DexCom, Inc.、GEHC GE HealthCare Technologies Inc.、PHG Koninklijke Philips N.V.

長期トレンド・直近動向・強気／弱気シナリオ・業績10年・バリュエーション・テクニカル・株主・役員・深掘り分析は会員向けです。

7日間無料で全文を読むログイン

次回決算: 2027-02-23 · 更新: 2026-10-09